Vertex Pharmaceuticals Inc $64.17

down -0.22


17/4/2014 08:10 PM  |  NASDAQ : VRTX  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get VRTX Trend Analysis - it has underperformed the S&P 500 by 1%

Partner Headlines

  1. Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours

    IBD
  2. House Probe Of Gilead's Sovaldi Price Hits Biotechs

    IBD
  3. Gilead Pricing Probed By House; Biotech Stocks Drop

    IBD
  4. Dow, S&P 500 Up, Nasdaq Slips; Drugmakers Falling Hard

    IBD
  5. BioMed Realty Trust Leases Space To Life Science Firms

    IBD
  6. Stocks Open Higher, Turn Mixed After Employement Report

    IBD
  7. Revenue Growth: Focus On Healthcare Stocks

    YCharts
  8. Enanta Joins Big Leagues With Hepatitis C Drug

    IBD
  9. Vertex drug trial results mixed

    IBD
  10. Vertex Cystic Fibrosis Trial Has Good, Bad News

    IBD
  11. Benzinga's Top #PreMarket Losers

    Benzinga
  12. Vertex Pharma Says Phase 3 Study Results of Ivacaftor Did Not Meet Primary ...

    Benzinga
  13. Trade Idea of the Day: Short Vertex

    Benzinga
  14. Nasdaq Leads Stocks Higher; Archer Daniels Deal Blocked

    IBD
  15. US Stock Futures Edge Lower Ahead Of FOMC Minutes, Economic Data

    Benzinga
  16. Vertex Sells INCIVO Product Royalty Rights to Janssen Pharmaceutica for ...

    Benzinga
  17. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga
  18. Vertex Drug, Fastest Blockbuster, Quickly Fading

    YCharts
  19. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, ...

    Benzinga
  20. Vertex Announces Oral Selective JAK3 Inhibitor VX-509 Shows Statistically ...

    Benzinga
  21. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  22. J&J Buys Glaxo Drug In Hunt For All-Oral HCV Therapy

    IBD
  23. Stocks Post Broad, Soft Losses; Amgen, Vertex Drag On Nasdaq

    IBD
  24. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga
  25. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, ...

    Benzinga
  26. Big Contingent Of Industries Outpace Nasdaq Rebound

    IBD
  27. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)

    Benzinga
  28. Pound For Pound, Are Biotechs Still Worth Their Salt?

    IBD
  29. Incyte Stock Soars As Drug Fights Pancreatic Cancer

    IBD
  30. Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells ...

    GuruFocus
  31. Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc. ...

    GuruFocus
  32. Market Wrap for Friday, July 26: Stocks Grind Out Small Gains to Close ...

    Benzinga
  33. Weekly Preview: Earnings Season Continues, Fed In Focus, Economic Maelstrom ...

    Benzinga
  34. Stocks Fight Back After Early Losses; China Names On Fire

    IBD
  35. Gilead Hits High As Vertex Stumbles In Hep C Race

    IBD
  36. Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)

    Benzinga
  37. Benzinga Market Primer: Friday, July 26: Futures Flat On Mixed Global Stocks ...

    Benzinga
  38. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  39. Vertex Pharmaceuticals (VRTX) CEO & President Jeffrey M Leiden sells 33,345 ...

    GuruFocus
  40. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  41. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
  42. Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC

    GuruFocus
  43. BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in ...

    Benzinga
  44. RIM, Green Mountain and Other Top Performing Nasdaq Stocks in November

    Benzinga
  45. Celgene, Regeneron Pharmaceutical Lead Biomed Group

    IBD
  46. Benzinga's M&A Chatter for Wednesday November 28, 2012

    Benzinga
  47. Vertex Pharmaceuticals (VRTX) EVP & CFO Ian F Smith sells 6,042 Shares

    GuruFocus
  48. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga
  49. UPDATE: Credit Suisse Downgrades Vertex Pharmaceuticals to Neutral on Competitive ...

    Benzinga
  50. Vertex Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
Trading Center